Advertisement
Research Article| Volume 64, ISSUE 3, P297-303, June 1984

Download started.

Ok

Antigalactocerebroside serum demyelinates optic nerve in vivo

  • Robert C. Sergott
    Correspondence
    Address reprint requests to Robert C. Sergott, M.D., Department of Neurology, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, U.S.A.
    Affiliations
    Department of Neurology, University of Pennsylvania School of Medicine Philadelphia, PA 19104 U.S.A.

    Department of Ophthalmology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 U.S.A.
    Search for articles by this author
  • Mark J. Brown
    Affiliations
    Department of Neurology, University of Pennsylvania School of Medicine Philadelphia, PA 19104 U.S.A.

    Department of Ophthalmology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 U.S.A.
    Search for articles by this author
  • Donald H. Silberberg
    Affiliations
    Department of Neurology, University of Pennsylvania School of Medicine Philadelphia, PA 19104 U.S.A.

    Department of Ophthalmology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 U.S.A.
    Search for articles by this author
  • Robert P. Lisak
    Affiliations
    Department of Neurology, University of Pennsylvania School of Medicine Philadelphia, PA 19104 U.S.A.

    Department of Ophthalmology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 U.S.A.
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Antiserum to the myelin lipid galactocerebroside (GalC) causes rapidly progressive focal demyelination when injected into guinea pig optic nerves. The capacity of anti-GalC to induce central nervous system demyelination is complement-dependent, and demyelinating activity is present in the immunoglobulin fraction of anti-GalC serum. Demyelination appears to result from primary damage to oligodendrocytes.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Dorfman S.H.
        • Fry J.M.
        • Silberberg D.H.
        • Grose C.
        • Manning M.C.
        Cerebroside antibody titers in antiserums capable of myelination inhibition and demyelination.
        Brain Res. 1978; 147: 410-415
        • Dubois-Dalcq M.
        • Niedieck B.
        • Buyse M.
        Action of anticerebroside sera on myelinated nervous tissue culture.
        Path. Europ. 1970; 5: 331-347
        • Fry J.M.
        • Lisak R.P.
        • Manning M.C.
        • Silberberg D.H.
        Serological techniques for detection of antibody to galactocerebroside.
        J. Immunol. Meth. 1976; 11: 185-193
        • Heide K.
        • Schwick H.C.
        Salt fractionation of immunoglobulins.
        in: Handbook of Experimental Immunology. Blackwell, Oxford1978: 7.1-7.11
        • Hirayama M.
        • Silberberg D.H.
        • Lisak R.P.
        • Pleasure D.
        Long-term culture of oligodendrocytes isolated from rat corpus callosum by percoll density gradient.
        J. Neuropath. Exp. Neurol. 1983; 42: 16-28
        • Lisak R.P.
        Multiple sclerosis — Evidence for immunopathogenesis.
        Neurology. 1980; 30: 99-105
        • Lisak R.P.
        • Abramsky O.
        • Dorfman S.H.
        • George J.
        • Manning M.C.
        • Pleasure D.E.
        • Saida T.
        • Silberberg D.H.
        Antibodies to galactocerebroside bind to oligodendroglia in suspension culture.
        J. Neurol. Sci. 1979; 40: 65-73
        • Ludwin S.K.
        • Johnson E.S.
        Evidence for a “dying-back” gliopathy in demyelinating disease.
        Ann. Neurol. 1981; 9: 301-305
        • Raff M.
        • Mirsky R.
        • Fields K.F.
        • Lisak R.P.
        • Dorfman S.H.
        • Silberberg D.H.
        • Gregson N.A.
        • Leibowitz S.
        • Kennedy M.C.
        Galactocerebroside — A specific cell surface antigenic marker for oligodendrocytes in culture.
        Nature (Lond.). 1978; 274: 813-816
        • Saida K.
        • Saida T.
        • Brown M.J.
        • Silberberg D.H.
        In vivo demyelination induced by intraneural injection of antigalactocerebroside serum — A morphological study.
        Amer. J. Path. 1979; 95: 99-116
        • Saida T.
        • Saida K.
        • Silberberg D.H.
        • Brown M.J.
        Transfer of demyelination with experimental allergic neuritis serum by intraneural injection.
        Nature (Lond.). 1978; 272: 639-641
        • Saida T.
        • Saida K.
        • Brown M.J.
        • Silberberg D.H.
        Peripheral nerve demyelination induced by intraneural injection of experimental allergic encephalomyelitis serum.
        J. Neuropath. Exp. Neurol. 1979; 38: 498-518
        • Saida T.
        • Saida K.
        • Dorfman S.H.
        • Silberberg D.H.
        • Sumner A.J.
        • Manning M.C.
        • Lisak R.P.
        • Brown M.J.
        Experimental allergic neuritis induced by sensitization with galactocerebroside.
        Science. 1979; 204: 1103-1106
        • Sergott R.C.
        • Brown M.J.
        • Silberberg D.H.
        Antiserum to galactocerebroside (GalC) demyelinates guinea pig optic nerve in vivo.
        Neurology. 1982; 32 (Abstr.): 85
        • Silberberg D.H.
        • Saida T.
        • Abramsky O.
        • Saida K.
        • Lisak R.
        • Pleasure D.
        Approaches to understanding the role of antibody in multiple sclerosis.
        in: Bauer H.G. Poser S. Titter G. Progress in Multiple Sclerosis Research. Springer-Verlag, Berlin1980: 216-220